Study to Determine the Phototoxity of Atralin (Tretinoin) Gel, 0.05%

Completed · Phase 1

Conditions studied: Healthy

In brief

To assess the potential of tretnoin gel 0.05% to produce phototoxic reactions, measured as skin reactions 24 and 48 hours after UV radiation of drug on skin.

Key facts

Study ID

NCT00604032

Run by

Coria Laboratories, Ltd.

People needed

60

Starts

2008-01-01

Expected to finish

2008-02-01

Last updated by the study team

2008-03-28

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Normal healthy volunteers
• 18 years of age or older

You may not qualify if…

• Less than 18 years of age

Where it is running

• Suncare Research Laboratories — Winston-Salem, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.